Metabolic Regulation Peptides Bioactive Toxin-Derived Peptides Tumor-Associated Antigen Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Neurodegenerative Disease Research Peptides Melanogenesis Modulation Anti-Aging & Skin Remodeling Gastrin, GRP & Bombesin Peptides Somatostatin Analogs DPPIV/CD26 Peptides Kinase Activity Modulators Caspase Substrates & Inhibitors Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Calcitonin & CGRP Family Peptides Incretin & Metabolic Peptides Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Peptide Coupling Reagents & Additives Specialty Peptide Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Neuromodulatory and Neuroactive Peptides Neurotransmitters/Neuropeptides Orexin B Rat/Mouse | Rodent OX2-Preferring Orexin Agonist

DESCRIPTION

Rat/mouse Orexin B is a 28-residue amidated hypothalamic neuropeptide and endogenous agonist of orexin receptors. Its rodent sequence differs from the human peptide at defined positions, making it useful for species-matched receptor and neuroscience studies.

Product Information

PropertySpecification
Catalog No.AS2717
CAS No.202801-92-1
SequenceArg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH₂
One-Letter SequenceRPGPPGLQGRLQRLLQANGNHAAGILTM-NH₂
Peptide Length28 amino-acid residues
Molecular FormulaC126H215N45O34S
Molecular WeightApproximately 2936.44 Da
C-TerminusMet-NH₂
Primary ReceptorsOX1R and OX2R, with stronger OX2-oriented pharmacology

Species-Matched Rodent Orexin B

Rodent Orexin B differs from human Orexin B at residues near the N-terminal and central regions. These naturally occurring substitutions allow species effects to be evaluated without introducing synthetic mutations.

For rat or mouse tissues and receptor systems, using the corresponding endogenous sequence reduces ambiguity when quantitative ligand responses are compared.

OX2-Oriented Orexin Pharmacology

Orexin B can activate both orexin receptor subtypes, but pharmacological studies generally show stronger activity at OX2R than OX1R. We recommend avoiding the absolute statement that Orexin B is “OX2-only,” because measurable OX1R activity has been demonstrated.

Research Applications

Applications include rodent orexin-receptor signaling, arousal and sleep-state research, feeding circuits, neural excitability and comparison with OX2-selective agonists.

Custom species variants can be evaluated through Chemical Peptide Synthesis.

Frequently Asked Questions

How many residues are in rat/mouse Orexin B?

The mature peptide contains 28 amino-acid residues, not 33.

Is the C-terminus amidated?

Yes. Mature rodent Orexin B terminates in Met-NH₂.

Research Use Only.

Orexin B Rat/Mouse | Rodent OX2-Preferring Orexin Agonist

Catalog No: AS2717
Cas No: 202801-92-1

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit